Alvogen, Lotus Pharmaceuticals Co. Ltd. deal

Lotus will issue to Alvogen up to 151 million shares of Lotus stock valued at about $200 million. Alvogen will hold about a 67% stake in Lotus, which will use the proceeds to acquire several of Alvoge...